Literature DB >> 9238330

Chronic telogen effluvium.

D A Whiting1.   

Abstract

Chronic telogen effluvium is not uncommon. It is a form of diffuse hair loss affecting the entire scalp for which no obvious cause can be found. It usually affects women of 30 to 60 years of age who generally have a full head of hair prior to the onset of shedding. The onset is usually abrupt, with or without a recognizable initiating factor. The degree of shedding is usually severe in the early stages and the hair may come out in handfuls. Chronic telogen effluvium has distinctive clinical and histologic features that are usually diagnostic. Chronic telogen effluvium contrasts with classic acute telogen effluvium by its persistence and its tendency to fluctuate for a period of years. Patients are particularly troubled by the continuing hair loss and fear total baldness. Repeated reassurance that the condition represents shedding rather than actual hair loss and does not cause complete baldness is necessary. Chronic telogen effluvium does appear to be self-limiting in the long run.

Entities:  

Mesh:

Year:  1996        PMID: 9238330     DOI: 10.1016/s0733-8635(05)70398-3

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  12 in total

Review 1.  Telogen Effluvium: A Review.

Authors:  Shashikant Malkud
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  Intermittent Chronic Telogen Effluvium.

Authors:  Alfredo Rebora
Journal:  Skin Appendage Disord       Date:  2017-01-28

Review 3.  Practical management of hair loss.

Authors:  J Shapiro; M Wiseman; H Lui
Journal:  Can Fam Physician       Date:  2000-07       Impact factor: 3.275

4.  Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria.

Authors:  Adriana Rakowska; Monika Slowinska; Elzbieta Kowalska-Oledzka; Malgorzata Olszewska; Lidia Rudnicka
Journal:  Int J Trichology       Date:  2009-07

Review 5.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

6.  Inducible, reversible hair loss in transgenic mice.

Authors:  Jingshan Chen; Max B Kelz; Guoqi Zeng; Cathy Steffen; Penny E Shockett; Gordon Terwilliger; David G Schatz; Eric J Nestler
Journal:  Transgenic Res       Date:  2002-06       Impact factor: 2.788

7.  Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study.

Authors:  Eshini Perera; Rodney Sinclair
Journal:  F1000Res       Date:  2017-09-06

Review 8.  Integral Roles of Specific Proteoglycans in Hair Growth and Hair Loss: Mechanisms behind the Bioactivity of Proteoglycan Replacement Therapy with Nourkrin® with Marilex® in Pattern Hair Loss and Telogen Effluvium.

Authors:  Jan Wadstein; Erling Thom; Aida Gadzhigoroeva
Journal:  Dermatol Res Pract       Date:  2020-05-05

9.  Alopecias in lupus erythematosus.

Authors:  Josef Symon Salgado Concha; Victoria P Werth
Journal:  Lupus Sci Med       Date:  2018-10-25

10.  Short Anagen Syndrome in an Indian Woman with its Impact on Quality-of-Life.

Authors:  Niteen V Dhepe; Ashok S Naik
Journal:  Int J Trichology       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.